These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18242086)

  • 41. First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
    Fontaine F; Hequet A; Voisin-Chiret AS; Bouillon A; Lesnard A; Cresteil T; Jolivalt C; Rault S
    J Med Chem; 2014 Mar; 57(6):2536-48. PubMed ID: 24499135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From 6-aminoquinolone antibacterials to 6-amino-7-thiopyranopyridinylquinolone ethyl esters as inhibitors of Staphylococcus aureus multidrug efflux pumps.
    Pieroni M; Dimovska M; Brincat JP; Sabatini S; Carosati E; Massari S; Kaatz GW; Fravolini A
    J Med Chem; 2010 Jun; 53(11):4466-80. PubMed ID: 20446747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology of efflux pumps genes mediating resistance among Staphylococcus aureus; A systematic review.
    Hassanzadeh S; Ganjloo S; Pourmand MR; Mashhadi R; Ghazvini K
    Microb Pathog; 2020 Feb; 139():103850. PubMed ID: 31706002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, structural, characterization, antibacterial and antibiotic modifying activity, ADMET study, molecular docking and dynamics of chalcone (
    Souza MA; Rodrigues LG; Rocha JE; de Freitas TS; Bandeira PN; Marinho MM; Nunes da Rocha M; Marinho ES; Honorato Barreto AC; Coutinho HDM; Silva LMA; Julião MSDS; Marques Canuto K; Marques da Fonseca A; Teixeira AMR; Dos Santos HS
    J Biomol Struct Dyn; 2024; 42(4):1670-1691. PubMed ID: 37222682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors.
    Sabatini S; Gosetto F; Serritella S; Manfroni G; Tabarrini O; Iraci N; Brincat JP; Carosati E; Villarini M; Kaatz GW; Cecchetti V
    J Med Chem; 2012 Apr; 55(7):3568-72. PubMed ID: 22432682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles.
    Holler JG; Slotved HC; Mølgaard P; Olsen CE; Christensen SB
    Bioorg Med Chem; 2012 Jul; 20(14):4514-21. PubMed ID: 22682300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the antibacterial activity of hecogenin acetate and its inhibitory potential of NorA and MepA efflux pumps from Staphylococcus aureus.
    Santos Araújo NJ; Pereira da Silva AR; Costa MDS; Pereira Silva CA; Sampaio de Freitas T; Oliveira de Sousa E; Barbosa Filho JM; Lobo Soares de Matos YM; Melo Coutinho HD; Andrade-Pinheiro JC
    Microb Pathog; 2023 Jan; 174():105925. PubMed ID: 36462578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
    Felicetti T; Cannalire R; Pietrella D; Latacz G; Lubelska A; Manfroni G; Barreca ML; Massari S; Tabarrini O; Kieć-Kononowicz K; Schindler BD; Kaatz GW; Cecchetti V; Sabatini S
    J Med Chem; 2018 Sep; 61(17):7827-7848. PubMed ID: 30067360
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and evaluation of new arylbenzo[b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
    Fournier Dit Chabert J; Marquez B; Neville L; Joucla L; Broussous S; Bouhours P; David E; Pellet-Rostaing S; Marquet B; Moreau N; Lemaire M
    Bioorg Med Chem; 2007 Jul; 15(13):4482-97. PubMed ID: 17498961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of antibacterial activity and reversal of the NorA and MepA efflux pump of estragole against Staphylococcus aureus bacteria.
    da Costa RHS; Rocha JE; de Freitas TS; Pereira RLS; Junior FNP; de Oliveira MRC; Batista FLA; Coutinho HDM; de Menezes IRA
    Arch Microbiol; 2021 Aug; 203(6):3551-3555. PubMed ID: 33942156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and Evaluation of 2-Aminothiophene Derivatives as Staphylococcus aureus Efflux Pump Inhibitors.
    da Cruz RMD; Zelli R; Benshain S; da Cruz RMD; Siqueira-Júnior JP; Décout JL; Mingeot-Leclercq MP; Mendonça-Junior FJB
    ChemMedChem; 2020 Apr; 15(8):716-725. PubMed ID: 32073756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel DiOC
    Elhidar N; Nafis A; Goehler A; Abbad A; Hassani L; Mezrioui NE; Bohnert JA
    J Microbiol Methods; 2021 Feb; 181():106128. PubMed ID: 33347918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro e in silico evaluation of the inhibition of Staphylococcus aureus efflux pumps by caffeic and gallic acid.
    Dos Santos JFS; Tintino SR; de Freitas TS; Campina FF; de A Menezes IR; Siqueira-Júnior JP; Coutinho HDM; Cunha FAB
    Comp Immunol Microbiol Infect Dis; 2018 Apr; 57():22-28. PubMed ID: 30017074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps.
    German N; Wei P; Kaatz GW; Kerns RJ
    Eur J Med Chem; 2008 Nov; 43(11):2453-63. PubMed ID: 18358571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sensitizing multi drug resistant
    Baiomy AA; Shaker GH; Abbas HA
    Afr Health Sci; 2020 Dec; 20(4):1632-1645. PubMed ID: 34394224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 3-Aryl-4-methyl-2-quinolones targeting multiresistant Staphylococcus aureus bacteria.
    Doléans-Jordheim A; Veron JB; Fendrich O; Bergeron E; Montagut-Romans A; Wong YS; Furdui B; Freney J; Dumontet C; Boumendjel A
    ChemMedChem; 2013 Apr; 8(4):652-7. PubMed ID: 23436688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liposomal nanoformulations with trans-caryophyllene and caryophyllene oxide: do they have an inhibitory action on the efflux pumps NorA, Tet(K), MsrA, and MepA?
    Santana JEG; Oliveira-Tintino CDM; Alencar GG; Siqueira GM; Almeida-Bezerra JW; Viana Rodrigues JP; Pinheiro Gonçalves VB; Nicolete R; Tintino SR; Coutinho HDM; Silva TGD
    Chem Biol Interact; 2024 Apr; 393():110945. PubMed ID: 38460934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
    Rieg S; Huth A; Kalbacher H; Kern WV
    Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of new 4-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]quinoxaline and 5-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]thieno[3,2-e]pyrazine derivatives, as potential bacterial multidrug resistance pump inhibitors.
    Vidaillac C; Guillon J; Moreau S; Arpin C; Lagardère A; Larrouture S; Dallemagne P; Caignard DH; Quentin C; Jarry C
    J Enzyme Inhib Med Chem; 2007 Oct; 22(5):620-31. PubMed ID: 18035830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The "racemic approach" in the evaluation of the enantiomeric NorA efflux pump inhibition activity of 2-phenylquinoline derivatives.
    Carotti A; Ianni F; Sabatini S; Di Michele A; Sardella R; Kaatz GW; Lindner W; Cecchetti V; Natalini B
    J Pharm Biomed Anal; 2016 Sep; 129():182-189. PubMed ID: 27429367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.